Hospital
Saint Louise Regional Hospital
Saint Louise Regional Hospital was paid $1.60M by Medicaid between Jan 2018 and Feb 2019, across 90 billing codes. Its largest line is 0450, Emergency room services — 38% of everything it billed.
33Billing provider infoSAINT LOUISE REGIONAL HOSPITAL
GILROY, CA 95020
GILROY, CA 95020
33aNPI1386746337assigned 09/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.60M
24GClaims54,058
24DCodes billed90
24AFirst – last monthJan 2018 – Feb 2019
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#260 of 410
Median peer was paid$6.90M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,941 | $1.38M | |
| 2019 | 8,117 | $225K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 38% | 2,942 | 2,681 | $604K |
| 80053 | Comprehensive metabolic panel | 17% | 2,779 | 2,603 | $275K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 9.8% | 1,054 | 526 | $156K |
| Z7502 | 6.2% | 2,690 | 2,678 | $100K | |
| 71046 | Radiologic examination, chest; 2 views | 4.6% | 781 | 763 | $73K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.1% | 440 | 423 | $50K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.5% | 2,821 | 2,654 | $41K |
| 81025 | 2.4% | 1,094 | 1,036 | $38K | |
| Z7610 | 1.4% | 1,625 | 878 | $22K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.1% | 1,297 | 1,187 | $18K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 474 | 430 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 404 | 398 | $16K |
78 more codes
| 71020 | <1% | 65 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,638 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,277 | $12K |
| 0516 | <1% | 205 | $11K | |
| 73610 | <1% | 85 | $10K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 976 | $9K |
| 0250 | <1% | 850 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 572 | $8K |
| 80306 | <1% | 313 | $8K | |
| J3490 | Unclassified drugs | <1% | 3,060 | $8K |
| 81001 | <1% | 1,735 | $7K | |
| 99284 | Emergency room visit (serious) | <1% | 1,642 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,060 | $6K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 285 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,684 | $5K |
| 73630 | <1% | 92 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 728 | $4K |
| 87400 | <1% | 236 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 893 | $4K |
| 74018 | <1% | 27 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 207 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 117 | $3K |
| 84702 | <1% | 319 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 159 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 409 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 251 | $2K |
| 82962 | <1% | 355 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 278 | $2K |
| 84484 | <1% | 603 | $2K | |
| 82553 | <1% | 302 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 486 | $1K |
| 73110 | <1% | 12 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 283 | $993.50 |
| 83690 | <1% | 1,162 | $771.65 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 652 | $760.36 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 347 | $750.99 |
| 87077 | <1% | 192 | $728.76 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 41 | $619.54 |
| 87280 | <1% | 81 | $617.68 | |
| 81003 | <1% | 990 | $585.32 | |
| 99285 | Emergency room visit (most serious) | <1% | 455 | $542.20 |
| 82550 | <1% | 346 | $506.09 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 238 | $405.52 |
| 0271 | <1% | 306 | $369.25 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 576 | $294.41 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 317 | $283.01 |
| 59025 | Fetal non-stress test | <1% | 16 | $225.63 |
| 87040 | <1% | 196 | $221.11 | |
| 36416 | <1% | 63 | $219.97 | |
| 85610 | <1% | 577 | $219.36 | |
| 85730 | <1% | 422 | $214.86 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 647 | $211.36 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 337 | $192.72 |
| 0272 | <1% | 207 | $171.98 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 25 | $163.58 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | $163.50 |
| 83735 | <1% | 301 | $162.60 | |
| 87186 | <1% | 172 | $158.77 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 26 | $139.32 |
| 83880 | <1% | 98 | $114.99 | |
| 83605 | <1% | 185 | $98.33 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 136 | $86.79 |
| 81002 | <1% | 26 | $54.44 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 42 | $35.39 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $27.73 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 55 | $23.55 |
| 86140 | <1% | 13 | $18.39 | |
| 86901 | <1% | 43 | $18.19 | |
| 86900 | <1% | 43 | $14.23 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 62 | $11.13 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $4.46 |
| 0270 | <1% | 166 | $0.82 | |
| A9270 | Non-covered item or service | <1% | 2,404 | $0.63 |
| G0378 | Hospital observation service, per hour | 0% | 12 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 369 | $0.00 |
| 0258 | 0% | 14 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 16 | $0.00 |
| 90715 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERGET, JORDAN (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| O'connor Hospital | San Jose, CA | $3.12M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.